Novartis settles for $340m – Greek subsidiary violated the FCPA

Author: Stavroula Verda Yet another bribery case violating the FCPA has been resolved through a Deferred Prosecution Agreement; Novartis Hellas S.A.C.I., a Greek subsidiary of Novartis A.G., has settled to avoid any further prosecution relevant to its illegal practices involving corrupt payments and their concealment. Another success to detect or failure to prevent corruption? Novartis […]

Read more